| 000 | 01096 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514033735.0 | ||
| 264 | 0 | _c20020624 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2402482 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarg, A | |
| 245 | 0 | 0 |
_aNuclear transcription factor-kappaB as a target for cancer drug development. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 2002 |
||
| 300 |
_a1053-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aAggarwal, B B | |
| 773 | 0 |
_tLeukemia _gvol. 16 _gno. 6 _gp. 1053-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2402482 _zAvailable from publisher's website |
| 999 |
_c11937200 _d11937200 |
||